MAIA Biotechnology, Inc.
Clinical-stage immuno-oncology company developing telomere-targeting cancer therapies.
MAIA | US
Overview
Corporate Details
- ISIN(s):
- US5526411021
- LEI:
- Country:
- United States of America
- Address:
- 444 WEST LAKE STREET, SUITE 1700, 60606 CHICAGO
- Website:
- https://maiabiotech.com/
- Sector:
- Manufacturing
Description
MAIA Biotechnology, Inc. is a clinical-stage immuno-oncology company focused on the development and commercialization of targeted therapies for cancer. The company develops potential first-in-class drugs with novel mechanisms of action, specializing in telomere-targeting agents. Its therapeutic approach utilizes immunotherapies designed to target telomeres in cancer cells. The company's pipeline products are currently under clinical investigation.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all MAIA Biotechnology, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for MAIA Biotechnology, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for MAIA Biotechnology, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
